SynBioBeta is where tech meets bio and bio meets tech.
Meet the innovators and companies, find new opportunities, partner up and discover the potential of the biological industrial revolution. Join us September 29 – October 1, 2020 in the Bay Area, California at the Oakland Marriott, to see how synthetic biology is disrupting consumer products, food, agriculture, medicine, chemicals, materials, and more.

Meet Dietmar Wolf in Oakland!

Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss the state of the art in drug discovery with academic experts and scientists from biotech and pharmaceutical industries. With topics focusing on anti-infectives, innovative screens, novel targets and target validation, computational approaches incl. artificial intelligence (AI) and more, this event will be an excellent opportunity to discuss the challenges and chances of modern drug discovery in academia and industry.

Meet Lutz Müller-Kuhrt in Braunschweig!

Cambridge Healthtech Institute’s 15th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one’s personal interests by going back and forth among concurrent conferences. The 2020 event includes new coverage of RNA as a small molecule target, expanded coverage of artificial intelligence for early drug discovery, plus even more short courses to choose from.

Meet Dietmar Wolf and Betsy McKibben at booth 204!

BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.

Meet Lars Ole Haustedt in Paris!

Future Food-Tech is a world-leading event series focusing on the most disruptive technologies transforming our food system. The flagship event, held in the innovation capital of the world – San Francisco – brings together 1000+ c-suite food brand executives, investors and entrepreneurs to share ideas, network, collaborate and invest.

Meet Dietmar Wolf in San Francisco!

The French Medicinal Chemistry Society (Société de Chimie Thérapeutique – SCT) is pleased to invite you to its 4th Meeting about Chemical Biology: Contribution to Molecular Therapeutic Innovation to be held in Paris, on March 10th, 2020.

RNA has already been drugged. Ribosomal RNA was drugged serendipitously with natural product antibiotics and later linezolid. A design-driven approach to drugging RNA was achieved with antisense oligonucleotides (ASOs) and then by RNA interference (RNAi) mechanisms.
More recently, small molecules that bind to the FMN riboswitch and to SMN2 pre-mRNA were reported and are close to clinical application. All those recent developments in the field of RNA-targeting definitely hold promise for future therapeutic applications.

Meet Lars Ole Haustedt in Paris!

Biologisch aktive Naturstoffe sind sowohl für die Grundlagenforschung als auch für die Forschung und Entwicklung der Pharma- und Agroindustrie von großer Bedeutung. Als guter Einblick in aktuelle Entwicklungen und als Forum für den interdisziplinären Erfahrungsaustausch sind die jährlich stattfindenden Irseer Naturstofftage der DECHEMA e.V. seit über drei Jahrzehnten ein fester Begriff. Sie werden von der Fachgruppe “Niedermolekulare Naturstoffe mit biologischer Aktivität” der DECHEMA e.V. organisiert.

Im Zentrum des diesjährigen 32. Symposiums stehen:

Synthese
Cannabinoide
Mikrobiome
Präbiotische Chemie

Treffen Sie Lutz Müller-Kuhrt, Karsten Siems und Lars Ole Haustedt in Irsee!

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

Meet Jens-Peter Müller in London!

The SLAS2020 scientific program features ten educational tracks, listed below:

Advances in Bioanalytics and Biomarkers
Assay Development and Screening
Automation and High-Throughput Technologies
Biologics Discovery
Cellular Technologies
Data Analysis and Informatics
Drug Target Strategies
Micro- and Nanotechnologies
Molecular Libraries
Precision Medicine Technologies

Meet Betsy McKibben at booth 2051 in San Diego!

Natural product discovery is currently undergoing a renaissance based to a large extent on the observations from microbial genome sequencing projects indicating that only a fraction of the potential microbial secondary metabolites from actinomycetes, other eubacteria, and fungi have been discovered so far, and that most secondary metabolite pathways are not expressed under normal laboratory growth conditions. However, the new discipline of “genome mining” has been exploring ways to activate the expression of these “cryptic pathways.”

Meet Dietmar Wolf in San Diego!

Successfully Optimize Target Validation, Improve
Drug-Like Properties & Accelerate the Translation of
Selective & Bioactive RNA Targeted Small Molecule
Therapeutics into Human Clinical Trials


Meet Betsy McKibben in Boston!